SGRP, no, but while its seasonally strong revenue wise, q4 lost money in fy '18 an '17 as well. EPS wise, March has made money, but June and Sept are very strong.
Point is...it could make a good buy if it sells off a bunch. Problem is, with most of their sales outside the US... lots in South America, I really don't know what the effect of the C-Virus wil be.
Market Data 
Markets 
AI
